Preclinical Trial Software

BIOiSIMTM is a first-in-class 'virtual drug development engine' that offers unprecedented value for the drug development industry by narrowing down the number of drug compounds that offer anticipated value for the treatment or cure of specific illness or disease. ...

Integrated AI to enhance your workflow, analysis, and results. Most efficient and scalable way to capture endoscopy video data sets for ...

Veeva CDB is a clinical data platform that aggregates and harmonizes all data sources so you get clean, well-organized data that is ready-to-use ...

Developed by scientists for scientists, VivoQuant is a robust and flexible visualization and quantitative analytic software program. VivoQuant addresses the needs of the imaging research community and solves common pain points in preclinical and clinical image analysis workflows. Click here to download the VivoQuant 2020 product flyer! ...

ELC1: LEPTOMENINGEAL CARCINOMATOSIS (LC). A devastating form of Cancer effecting 110,000 Patients/Yr. US, with a current life expectancy 2-7 months. Involvement by cancer of pia & arachnoid mater of the brain with the subarachnoid space in between. High incidence from breast, lung & ...

Ontosight Explore enables the exploration, detection and building of various direct and in-direct connections between drug, target, pathway and disease. We leverage a biological network model using enhanced natural language processing, statistical scoring approach and entity normalization. Our self learning, life science ontology, has more than 20 million concepts and terms and brings together ...

Ontosight® Discover – a one stop solution for all relevant information within the pharmaceutical industry. The AI and blockchain powered discovery engine connects trillions of data points to accelerate your drug discovery and research process. You get real-time data insights on a fingertip for empowered, inspired & faster decisions. Automate up to 80% of your data intelligence work: ...

Intelligent Digital Pathology Solution: Xybion is dedicated to the advancement of software solutions for preclinical and toxicologic pathology. Our Digital Pathology software greatly increases productivity and lab throughput while allowing pathologists to streamline their workflows and review slides more efficiently. Our Digital Pathology software provides unique competitive and ...

Your next pathology-based CDx starts here. With the complexity of therapies increasing, the need for a robust companion diagnostic (CDx) has never been higher. Advances in tissue analysis technologies now require a more quantitative, accurate, and precise pathology-based CDx. Bringing your CDx to market requires a solid strategy to meet strict regulatory standards and critical timelines. Your CDx ...

ecgAUTO is an in-depth cardiovascular analysis software. From multiple species or leads, it uses shape recognition techniques for interval analysis, arrhythmia detection, heart rate variability, blood pressure assessment, etc. Features include customizable parameters and protocols, interactive dashboards, batch analysis, comprehensive data reports, and more. Optional GLP modules and SEND ...

Ovation's genomic data solutions enable life science and biopharma companies to accelerate research and development across a wide range of therapeutic areas including autoimmune, metabolic, and infectious ...

We have an ongoing Phase 1 sub-study exploring whether Lomecel-B can improve the Metabolic Syndrome, and if the Metabolic Syndrome presents confounding issues for this treatment approach in Aging Frailty patients. This sub-study primarily focuses upon blood-based biomarker changes, and non-invasive evaluation of vascular (blood vessel) ...

Cypre’s 3D Tumor Models combine the tumor, stromal and immune compartments in a high throughput format to screen targeted drugs and immunotherapy. In 2021, we partnered with Charles River to offer our 3D Tumor Models for drug discovery and preclinical screening services. Cypre Panels rapidly screen small molecules, biologics and cell therapy in 3D hydrogel in vitro tumor ...